CYTIMMUNE SCIENCES INC

Profile

Company Names

CYTIMMUNE SCIENCES INC

Addresses

15010 BROSCHART ROAD, SUITE 270, ROCKVILLE, MD 20850

15010 BROSCHART ROAD, ROCKVILLE, MD 20850

9640 MEDICAL CENTER DR, ROCKVILLE, MD 20850

Phone Numbers

301-825-3041
240-864-2791

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$9,556,303.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2020-12-10 
$997,798.00 
$3,000,000.00 
$2,002,202.00 
Equity, Debt 
11
2020-04-13 
$50,000.00 
$500,000.00 
$450,000.00 
Equity 
10
2019-03-19 
$75,000.00 
$500,000.00 
$425,000.00 
Equity 
9
2017-10-02 
$30,000.00 
$2,000,000.00 
$1,970,000.00 
Debt 
8
2016-12-21 
$100,849.00 
$2,999,850.00 
$2,899,001.00 
Equity 
7
2015-08-14 
$747,666.00 
$2,000,000.00 
$1,252,334.00 
Equity 
6
2014-09-03 
$689,990.00 
$1,000,000.00 
$310,010.00 
Equity 
5
2014-05-12 
$400,000.00 
$1,200,000.00 
$800,000.00 
Equity 
4
2014-03-31 
$5,410,000.00 
$5,410,000.00 
$0.00 
Equity, Debt 
3
2013-05-01 
$30,000.00 
$1,000,000.00 
$970,000.00 
Equity 
2
2012-02-17 
$25,000.00 
$1,000,000.00 
$975,000.00 
Equity 
1
2009-09-18 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ASHTON 
DIRECTOR
NEAL 
 
COHEN 
DIRECTOR
NEAL 
 
COHNE 
DIRECTOR
MARK 
D. 
GILBERT 
DIRECTOR
JOHN 
W. 
HOLADAY 
DIRECTOR
HIDETAKA 
KENTARO 
ITANI 
DIRECTOR
JASON 
 
LEVINE 
EXECUTIVE OFFICER
JASON 
H. 
LEVINE 
EXECUTIVE OFFICER
SABA 
S. 
MALAK 
EXECUTIVE OFFICER, DIRECTOR
MITCHELL 
S. 
MARDER 
EXECUTIVE OFFICER
DAVID 
 
OARR 
EXECUTIVE OFFICER
DAVID 
M. 
OARR 
EXECUTIVE OFFICER
GIULIO 
F. 
PACIOTTI 
EXECUTIVE OFFICER
GARY 
 
ROSENFELD 
EXECUTIVE OFFICER
IRA 
 
SHAPIRO 
DIRECTOR
MARC 
 
STANLEY 
DIRECTOR
LAWRENCE 
 
TAMARKIN 
EXECUTIVE OFFICER, DIRECTOR
KENNETH 
B. 
WHITE 
DIRECTOR
NORMAN 
 
ZOBER 
DIRECTOR
NORMAN 
A. 
ZOBER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-12-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-03-31 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-05-01 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-02-17 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-09-18 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-09-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#